South-Korea (한국어)
South-Korea (한국어)

Preclinical medical device testing

3D print realistic, pathology-specific anatomy.

Improve medical device design by testing on clinically relevant anatomical models. 3D print models based on real patient imaging and mimic a variety of tissue properties in a single print.

Validation limitations.

Preclinical studies are an essential step in protecting patient safety, meeting regulatory requirements and evaluating a new device’s potential to solve an unmet clinical need. Existing models used to evaluate device performance, such as animals and cadavers, present significant limitations: they can be expensive or difficult to obtain, require a controlled environment, and often don't represent the targeted pathology precisely.

Due to these limitations, tissue and anatomical disparities can obscure design deficiencies, leaving them to be discovered later when they're more costly to correct. What’s more, planning, procurement and biohazard controls introduce considerable costs and lead times early in the product lifecycle.

Improve clinical relevance.

Prior to in vivo evaluation, validate device performance on patient-derived 3D printed anatomical models. Realistic, pathology-specific anatomy can guide development from early design parameters all the way through to statistical validation.

  • Gain certainty by validating device performance on models that represent a range of clinical cases. You can simulate blood flow, embed sensors, and mimic a variety of tissue properties.
  • Test anywhere without the complex logistics of procuring test specimens and securing a controlled environment.
  • Mitigate cost overruns by reducing the likelihood of repeated in-vivo evaluations. 3D printed models are far less expensive, so you can get your device on solid footing before making that investment.